Stay updated with breaking news from Nasdaq Eigr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report released on Saturday. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup reduced their price objective on Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating for the company in a research note […]
StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Citigroup decreased their target price on Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating for the company in a […]
StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report sent to investors on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup dropped their price objective on Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating on the stock in […]
StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a report published on Thursday. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup reduced their price target on Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating for the company in a report on Tuesday, […]
Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) will release its earnings data on Friday, November 3rd. Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) last released its quarterly earnings data on Monday, August 14th. The biotechnology company reported ($0.47) earnings per share (EPS) for the quarter. Eiger BioPharmaceuticals had a negative return on equity of 207.93% […]